Market Introduction of Medical Devices
sananet also advises on practical matters during the market introduction of your medical devices, e.g. visiting a user of the prototype.
- Normal customers
- Crowding out competition
- KOL (early adopters)
We would summarize these 3 points in the market launch of the medical product as the first project phase under the heading “Qualitative market study”.
As a result of this phase, you will receive a basic assessment of whether market entry makes sense at all and where major risks lie. Possible alternative paths will be pointed out if possible.
As an example, problems with reimbursement, given medical and technical feasibility, could make the market launch of your medical product very difficult. In this case, alternative concepts such as the IGeL case, i.e. private reimbursement by the patient, or benefit argumentation via business case would have to be considered.
After the first phase, you will have a decision basis for a market launch. If you then decide to launch the project, we recommend a more detailed market study (point 4).
User visit in the course of the market launch for a medical product
sananet also advises on very practical matters during the market launch of your new medical product, e.g. visiting a user of the prototype. This includes participation in tests, discussion with the user, etc.
The aim is to be able to better assess the development status, customer benefits and user-friendliness.
Risks associated with the market launch of innovative medical devices
The risk with innovative medical devices is that the transition from key opinion leaders as early adopters to normal customers is misjudged.
This transition must be well planned in the market launch strategy. The prerequisites for selling to standard customers must be in place
